Related references
Note: Only part of the references are listed.The Role of Oxidative Stress in Peripheral Neuropathy
Marie-Louise Mallet et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Role of Phosphodiesterase in the Biology and Pathology of Diabetes
Agnieszka Kilanowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy
Gidon J. Boenhof et al.
ENDOCRINE REVIEWS (2019)
Prevalence, Patterns, and Factors Associated with Peripheral Neuropathies among Diabetic Patients at Tertiary Hospital in the Kilimanjaro Region: Descriptive Cross-Sectional Study from North-Eastern Tanzania
Ahlam A. Amour et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2019)
Differential Effects of Pentoxifylline on Learning and Memory Impairment Induced by Hypoxic-ischemic Brain Injury in Rats
Hulya Halis et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis
Nasrin Sadeghiyan Galeshkalami et al.
LIFE SCIENCES (2019)
Effect of pentoxifylline on diabetic distal polyneuropathy in type 2 diabetic patients: A randomized trial
Frahad Hosseini et al.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
Saikat Dewanjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Phosphodiesterase 4 and 7 inhibitors produce protective effects against high glucose-induced neurotoxicity in PC12 cells via modulation of the oxidative stress, apoptosis and inflammation pathways
Nazanin Namazi Sarvestani et al.
METABOLIC BRAIN DISEASE (2018)
Sildenafil protective effects on high glucose-induced neurotoxicity in PC12 cells: the role of oxidative stress, apoptosis, and inflammation pathways in an in vitro cellular model for diabetic neuropathy
Saeedeh Saberi Firouzi et al.
NEUROLOGICAL RESEARCH (2018)
Neuroprotective effect of cerium oxide nanoparticles in a rat model of experimental diabetic neuropathy
Rezvan Najafi et al.
BRAIN RESEARCH BULLETIN (2017)
Anti-oxidative and anti-inflammatory effects of cinnamaldehyde on protecting high glucose-induced damage in cultured dorsal root ganglion neurons of rats
Yang Dan et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2016)
Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats
Yeye Zhuo et al.
METABOLIC BRAIN DISEASE (2016)
The Analgesic Effect of Rolipram, a Phosphodiesterase 4 Inhibitor, on Chemotherapy-Induced Neuropathic Pain in Rats
Hee Kee Kim et al.
ANESTHESIA AND ANALGESIA (2015)
Burning through the pain: treatments for diabetic neuropathy
S. Javed et al.
DIABETES OBESITY & METABOLISM (2015)
Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthase
Francisca Adilfa de Oliveira Garcia et al.
JOURNAL OF INFLAMMATION-LONDON (2015)
Neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells
Habib Ghaznavi et al.
NEUROLOGICAL RESEARCH (2015)
Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
Miguel Perez-Aso et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Antioxidant Strategies in the Management of Diabetic Neuropathy
Ayodeji Babatunde Oyenihi et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson's Disease
Kelly Rose Tavares Neves et al.
PARKINSONS DISEASE (2015)
Cerium and Yttrium Oxide Nanoparticles Against Lead-Induced Oxidative Stress and Apoptosis in Rat Hippocampus
Asieh Hosseini et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2015)
Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells
Rezvan Najafi et al.
METABOLIC BRAIN DISEASE (2015)
Neuroinflammation and Oxidative Stress in Diabetic Neuropathy: Futuristic Strategies Based on These Targets
Reddemma Sandireddy et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2/HO-1 activation and NF-κB inhibition
Yue Shi et al.
ACTA PHARMACOLOGICA SINICA (2013)
Diabetic Neuropathy and Oxidative Stress: Therapeutic Perspectives
Asieh Hosseini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
A Systematic Review: Current and Future Directions of Dorsal Root Ganglion Therapeutics to Treat Chronic Pain
Jason E. Pope et al.
PAIN MEDICINE (2013)
Combination of Alpha Lipoic Acid and Superoxide Dismutase Leads to Physiological and Symptomatic Improvements in Diabetic Neuropathy
Fulvio Bertolotto et al.
Drugs in research & development (2013)
Electrophysiological and Behavioral Changes by Phosphodiesterase 4 Inhibitor in a Rat Model of Alcoholic Neuropathy
Kyoung-Hee Han et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2012)
Protective Effect of Magnesium-25 Carrying Porphyrin-Fullerene Nanoparticles on Degeneration of Dorsal Root Ganglion Neurons and Motor Function in Experimental Diabetic Neuropathy
Asieh Hosseini et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)
Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals
T. Luna et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2011)
Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications
Eric P. Davidson et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
A Selective Phosphodiesterase-4 Inhibitor Reduces Leukocyte Infiltration, Oxidative Processes, and Tissue Damage after Spinal Cord Injury
Feng Bao et al.
JOURNAL OF NEUROTRAUMA (2011)
Amelioration of experimental colitis by a novel nanoselenium--silymarin mixture
Amir Ebrahim Miroliaee et al.
TOXICOLOGY MECHANISMS AND METHODS (2011)
The Effect of Phosphodiesterase-4-Specific Inhibitor in the Rat Model of Spinal Nerve Ligation
Sung Hoon Kim et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2011)
Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy
Andrea M. Vincent et al.
ACTA NEUROPATHOLOGICA (2010)
Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy
Abdollahi
International Journal of Nanomedicine (2010)
NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection
Nikolaos Volakakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
IMMUNOMODULATORY PROPERTIES OF PENTOXIFYLLINE ARE MEDIATED VIA ADENOSINE-DEPENDENT PATHWAYS
Simone Kreth et al.
SHOCK (2010)
Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus
Boglarka Laczy et al.
ACTA DIABETOLOGICA (2009)
Diabetes and the peripheral nerve
Irina G. Obrosova
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Administration of phosphodiesterase inhibitors and an adenosine A1 receptor antagonist induces phrenic nerve recovery in high cervical spinal cord injured rats
S. Kajana et al.
EXPERIMENTAL NEUROLOGY (2008)
The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury
Sari S. Hannila et al.
EXPERIMENTAL NEUROLOGY (2008)
Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain
Jian Liu et al.
NEUROSCIENCE LETTERS (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Phosphodiesterase inhibitors in airways disease
KF Chung
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Phosphodiesterase-4 as a therapeutic target
MD Houslay et al.
DRUG DISCOVERY TODAY (2005)
Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial
M Radfar et al.
BIOMEDICINE & PHARMACOTHERAPY (2005)
Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats
E Milani et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2005)
Oxidative stress in the pathogenesis of diabetic neuropathy
AM Vincent et al.
ENDOCRINE REVIEWS (2004)
An interventional approach to block brain damage caused by Shiga toxin-producing Escherichia coli infection, by use of a combination of phosphodiesterase inhibitors
A Okayama et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Activation of the mitogen-activated protein kinase (ERK1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons
JD Troadec et al.
MOLECULAR PHARMACOLOGY (2002)
Oxidative stress and diabetic neuropathy: pathophysiotogical mechanisms and treatment perspectives
PS van Dam
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy
M Kishi et al.
DIABETES (2002)
The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo
E Beshay et al.
CLINICAL IMMUNOLOGY (2001)
Share Paper
